Cutting the worrying and the waiting

The TRIOMIC study, in partnership with the Shrewsbury and Telford Hospital, will reduce the time patients have to wait and worry about a colorectal cancer diagnosis. A new rapid and pain-free test – using the Oricol™ device – is being developed as part of the study which aims to drastically reduce the number of patients who require an invasive colonoscopy. It is taking place at the Community Diagnostics Centre at Hollinswood House, Stafford Park - away from a hospital setting.

Over the course of a year, around 6,000 symptomatic patients on the Colorectal Urgent Suspected Cancer pathway at The Shrewsbury and Telford Hospital NHS Trust (SaTH) will be recruited to take part.

80% of patients to get the all clear within five days

If successful, this could mean the Oricol device will allow eight out of ten patients to wait only five days to receive confirmation that they do not have cancer. Currently, many patients undergo a 45-minute colonoscopy, which involves full bowel preparation and a separate hospital visit. Only to wait a further 3 weeks for their results.

Alongside improving the patient experience, the study will also ease pressure on overstretched hospital staff and reduce costs for the NHS.

Origin Sciences is funding staff and capital costs to develop the new pathway – three new clinic rooms are being created at the CDC, and 14 additional staff have been recruited.

This study is sponsored by TOGL.